Pharma Surge
Pharma Surge
Intelligence Layer
🇺🇸·Feb 10Devices

PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExploreTM for Standardized Histopathology Endpoints

Publisher

P
PathAI

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
PathAI
Region
USA
Scope
Devices
Published
February 10, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on pathai.com

Leave the platform to read the original full article on the publisher site.

Source: PathAI

Scope: Devices

Open original article
PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExploreTM for Standardized Histopathology Endpoints | Pharma Surge